Are Patent Exceptions Necessary For Climate Change Technology? Defining WIPO’s Role 26/03/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments Addressing the challenge of climate change will require technological solutions and the dissemination of those solutions to as many users as possible. A panel at the World Intellectual Property Organization Tuesday asked how intellectual property law might help or hinder that transfer, and what role the organisation might play in creating the right policy.
WIPO, UNCITRAL Team Up On IP And Finance 20/03/2009 by William New, Intellectual Property Watch Leave a Comment Officials from two lawyerly United Nations agencies met recently to discuss their roles and build cooperation in intellectual property finance, especially in light of the global economic crisis.
Kenya Conference: Financial Incentives Needed For Tailored Neglected Disease Research 16/03/2009 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment NAIROBI – Governments in Kenya and other developing nations must be willing to provide financial incentives if they expect companies to carry out research and development of drugs specifically tailored to those countries’ needs, a conference in Nairobi was told last week.
WHO Launches Online Hearing On Innovative Funding Sources For R&D 06/03/2009 by William New, Intellectual Property Watch 1 Comment The World Health Organization is soliciting new ideas for funding sources to stimulate research and development on diseases predominantly afflicting developing countries, with some in developed countries. The web-based public hearing, being held online from 7 March to 15 April, will contribute to an intergovernmental mandate to come up with ways to address the shortage of research in this areas.
Path Forward For UN-Led Internet Governance Forum Discussed 26/02/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment That there will be a future for the international Internet Governance Forum seems likely, though the form its future incarnation will take is not. Delegates to an open consultation on internet governance this week began to sort out some base modalities on how to evaluate the progress of the United Nations-led discussion venue, as a deadline approaches to decide whether and how the group will continue.
欧盟有关知识产权的强硬规定被视为对贫困国家医药获得的威胁 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment 布鲁塞尔 – 全球公共卫生活跃分子声称，欧盟执意要在一系列自由贸易协议中添加有关医药专利的强硬规定将会妨害发展中国家获得医药。
International Health Groups Warn WHO, WTO On Medicines Seizures 21/02/2009 by William New, Intellectual Property Watch 7 Comments Leading international public health advocates have sent letters to the heads of the World Health Organization and World Trade Organization calling on them to act to prevent possible circumvention of international trade rules for intellectual property rights relating to shipments of legal generic drugs bound for developing countries.
Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access 18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged. As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
WHO Global Strategy On IP And Health Considered, Implementation Advances 28/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara Progress made on the World Health Organization strategy on public health and innovation was highlighted to WHO members on Saturday, including the production of a key budgeting document detailing timeframes and estimated costs of implementing the strategy. The Global Strategy and Plan of Action on Health, Innovation and Intellectual Property was discussed […]
Counterfeit Medication, R&D Financing Key IP Issues At WHO Board Meeting 16/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara The Executive Board of the World Health Organization meets next week with significant discussion expected on a new secretariat report on counterfeit medical products as well as on the implementation of the WHO’s mandated global strategy on public health, innovation, and intellectual property. There has been significant interest from a variety of […]